Patton Fund Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.69M Buy
+6,906
New +$2.76M 0.69% 51
2026
Q2
– Sell
-732
Closed -$214K – 214
2026
Q1
$214K Buy
+732
New +$241K 0.04% 451
2025
Q4
– Sell
-685
Closed -$221K – 478
2025
Q3
$221K Buy
+685
New +$213K 0.04% 376
2023
Q1
– Sell
-402
Closed -$206K – 133
2022
Q4
$206K Buy
+402
New +$204K 0.06% 160
2019
Q3
– Sell
-7,425
Closed -$2.1M – 82
2019
Q2
$2.1M Buy
+7,425
New +$2.03M 0.83% 51

Other funds holding ELV

Patton Fund Management's ELV Position: Q3 2026 in Review

Patton Fund Management opened a new position in Elevance Health (ELV) in Q3 2026: 6,906 shares worth $2.69M. The stake represents 0.69% of the portfolio and ranks #51 among its holdings. This is a return to the name: Patton Fund Management previously reported a position in ELV as recently as Q1 2026.

Patton Fund Management first reported a position in ELV in Q2 2019 and has held it in 5 quarters since. 929 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Patton Fund Management held 6,906 shares of Elevance Health worth $2.69M as of Q3 2026.
  • Elevance Health was a new Patton Fund Management position in Q3 2026.
  • Elevance Health made up 0.69% of Patton Fund Management's portfolio in Q3 2026, its #51 holding.
  • Patton Fund Management first reported a position in Elevance Health in Q2 2019 and has held it in 5 quarters since.
  • 929 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Patton Fund Management's 13F filing for Q3 2026, filed 13 Oct 2026.